Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxlovid for Long COVID Prevention (PanoramicNOR)
NCT05852873Phase 3Active, not recruiting
- Sponsor
- Haukeland University Hospital
- Start
- May 2023
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Nirmatrelvir in coronavirus disease 2019 (COVID-19), sponsored by Haukeland University Hospital. Started May 2023; status: active, not recruiting.
02
Drugs
Nirmatrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05852873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05852873.